US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025.

from Wired https://ift.tt/tpQ3HNd

Comments

Popular posts from this blog

Tableau launches new enterprise plans, big data tools

CanvasChamp is the perfect way to transform your home in the new year

These Cyber Monday running shoe deals include 50% off some of our favorite pairs